• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子受体和辅因子功能所需的磷脂非依赖性和依赖性相互作用。

Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.

作者信息

Ruf W, Rehemtulla A, Morrissey J H, Edgington T S

机构信息

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, California 92037.

出版信息

J Biol Chem. 1991 Feb 5;266(4):2158-66.

PMID:1989976
Abstract

Membrane anchoring of tissue factor (TF), the cell receptor for coagulation factor VIIa (VIIa), exemplifies an effective mechanism to localize proteolysis at the cell surface. A recombinant TF mutant (TF1-219), deleted of membrane spanning and intracellular domains, was used to evaluate the role of phospholipid interactions for assembly of substrate with the catalytic TF.VIIa complex. TF1-219 was secreted by cells rather than expressed as a cell membrane protein. Unlike free VIIa, TF1-219 as well as the TF1-219.VIIa complex demonstrated no stable association with phospholipid. In the absence of lipid, kinetic evaluation of substrate factor X cleavage by free VIIa, TF.VIIa, and TF1-219.VIIa suggests that the catalytic function of VIIa rather than substrate recognition is enhanced by complex formation. Furthermore, compared with free factor X, factor X on phospholipid was preferentially cleaved as a substrate by TF1-219.VIIa. TF-dependent initiation of the coagulation protease cascades thus involves an enhancement of the activation of factor X on the cell surface by a crucial role of the TF transmembrane domain to membrane anchor the reaction, by the TF extracellular domain to provide protein-protein interactions with VIIa to enhance the activity of the catalytic domain of VIIa, and the preferential presentation of factor X as a substrate when associated with phospholipid surfaces.

摘要

组织因子(TF)是凝血因子VIIa(VIIa)的细胞受体,其膜锚定是在细胞表面定位蛋白水解的一种有效机制。一种缺失跨膜和细胞内结构域的重组TF突变体(TF1-219)被用于评估磷脂相互作用在底物与催化性TF.VIIa复合物组装中的作用。TF1-219由细胞分泌,而非作为细胞膜蛋白表达。与游离的VIIa不同,TF1-219以及TF1-219.VIIa复合物与磷脂没有稳定的结合。在没有脂质的情况下,对游离VIIa、TF.VIIa和TF1-219.VIIa切割底物因子X的动力学评估表明,复合物形成增强了VIIa的催化功能而非底物识别功能。此外,与游离因子X相比,磷脂上的因子X作为底物被TF1-219.VIIa优先切割。因此,TF依赖的凝血蛋白酶级联反应的启动涉及通过TF跨膜结构域对反应进行膜锚定、TF细胞外结构域与VIIa提供蛋白质-蛋白质相互作用以增强VIIa催化结构域的活性以及因子X与磷脂表面结合时作为底物的优先呈现,从而增强细胞表面因子X的激活。

相似文献

1
Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function.组织因子受体和辅因子功能所需的磷脂非依赖性和依赖性相互作用。
J Biol Chem. 1991 Feb 5;266(4):2158-66.
2
Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex.辅助因子残基赖氨酸165和166对于组织因子-因子VIIa蛋白酶复合物识别蛋白质底物至关重要。
J Biol Chem. 1992 Mar 25;267(9):6375-81.
3
Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.凝血因子VIIaγ-羧基谷氨酸结构域中精氨酸-36残基对大分子底物凝血因子Xγ-羧基谷氨酸结构域识别的重要性。
Biochemistry. 1999 Feb 16;38(7):1957-66. doi: 10.1021/bi982254r.
4
The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.可溶性突变组织因子在增强因子VIIa蛋白水解活性方面明显缺陷的生化基础。
J Biol Chem. 1994 Jan 7;269(1):143-9.
5
Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.磷脂表面调节底物向组织因子:VIIa的递送以及产物的清除。
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):194-8. doi: 10.1016/j.bcmd.2005.12.032. Epub 2006 Mar 9.
6
Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.磷脂通过底物和产物相互作用调节组织因子/因子VIIa(TF/VIIa)对因子X的激活。
Biochemistry. 2005 Jun 7;44(22):8187-97. doi: 10.1021/bi050338b.
7
Influence of mutations in tissue factor on the fine specificity of macromolecular substrate activation.组织因子突变对大分子底物激活精细特异性的影响。
Biochem J. 1997 Feb 1;321 ( Pt 3)(Pt 3):787-93. doi: 10.1042/bj3210787.
8
Characterization of factor VII association with tissue factor in solution. High and low affinity calcium binding sites in factor VII contribute to functionally distinct interactions.
J Biol Chem. 1991 Aug 25;266(24):15719-25.
9
The interaction of human factor VIIa with tissue factor.人凝血因子VIIa与组织因子的相互作用。
J Biol Chem. 1992 Nov 25;267(33):23696-706.
10
Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.组织因子残基赖氨酸165和赖氨酸166对于组织因子-VIIa与Xa、组织因子途径抑制物的四元复合物的快速形成至关重要。
Biochemistry. 1995 Aug 29;34(34):10867-71. doi: 10.1021/bi00034a020.

引用本文的文献

1
Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism.组织因子/因子VIIa复合物与X因子模拟物的冷冻电镜结构揭示了一种新型变构机制。
Blood. 2025 Aug 14. doi: 10.1182/blood.2025029430.
2
The unfolded protein response links ER stress to cancer-associated thrombosis.未折叠蛋白反应将内质网应激与癌症相关的血栓形成联系起来。
JCI Insight. 2023 Aug 31;8(19):e170148. doi: 10.1172/jci.insight.170148.
3
Active recruitment of anti-PD-1-conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy.
通过肿瘤选择性血栓形成主动募集抗 PD-1 偶联血小板以增强抗癌免疫治疗。
Sci Adv. 2023 Mar 29;9(13):eadf6854. doi: 10.1126/sciadv.adf6854.
4
Extracellular Vesicles in Sickle Cell Disease: A Promising Tool.镰状细胞病中的细胞外囊泡:一种有前景的工具。
Bioengineering (Basel). 2022 Sep 5;9(9):439. doi: 10.3390/bioengineering9090439.
5
Effect of lower-leg trauma and knee arthroscopy on procoagulant phospholipid-dependent activity.小腿创伤和膝关节镜检查对促凝血磷脂依赖性活性的影响。
Res Pract Thromb Haemost. 2022 Jun 8;6(4):e12729. doi: 10.1002/rth2.12729. eCollection 2022 May.
6
Plasma procoagulant phospholipid clotting time and venous thromboembolism risk.血浆促凝磷脂凝血时间与静脉血栓栓塞风险
Res Pract Thromb Haemost. 2021 Dec 20;5(8):e12640. doi: 10.1002/rth2.12640. eCollection 2021 Dec.
7
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.在成人和儿科血友病伴有抑制物的患者中,使用活化eptacog beta 治疗出血发作和围手术期止血的安全性。
Haemophilia. 2021 Nov;27(6):921-931. doi: 10.1111/hae.14419. Epub 2021 Oct 11.
8
Molecularly engineered truncated tissue factor with therapeutic aptamers for tumor-targeted delivery and vascular infarction.具有治疗性适配体的分子工程化截短组织因子,用于肿瘤靶向递送和血管梗死。
Acta Pharm Sin B. 2021 Jul;11(7):2059-2069. doi: 10.1016/j.apsb.2020.11.014. Epub 2020 Nov 24.
9
Structure of human factor VIIa-soluble tissue factor with calcium, magnesium and rubidium.人因子 VIIa-可溶性组织因子与钙、镁和铷的结构。
Acta Crystallogr D Struct Biol. 2021 Jun 1;77(Pt 6):809-819. doi: 10.1107/S2059798321003922. Epub 2021 May 14.
10
Fibrinogen-related protein, FGL2, of hamster cauda epididymal fluid: Purification, kinetic analysis of its prothrombinase activity, and its role in segregation of nonviable spermatozoa.仓鼠尾部附睾液中纤维蛋白原相关蛋白 FGL2 的纯化、其凝血酶原酶活性的动力学分析及其在非存活精子分离中的作用。
Mol Reprod Dev. 2020 Dec;87(12):1206-1218. doi: 10.1002/mrd.23438. Epub 2020 Nov 20.